Research - March 2017 Archives

Ocrevus (ocrelizumab), a new drug to treat multiple sclerosis (MS),  has been approved by the U.S. Food and Drug Administration (FDA). The National Multiple Sclerosis ...

ROCHESTER, Minn.— For many people diagnosed with heart failure – which almost invariably results in a hospital stay – the next stop is a skilled ...

Renaissance means rebirth or regeneration. Every few generations medicine takes a major turn. We’re at one of those junctures now with regenerative medicine — ...

We here at In the Loop love a story with a happy ending. (We have a hunch you do, too.) And it's hard to ...

ROCHESTER Minn. – Researchers at Mayo Clinic have identified an interaction among proteins that allows cancer cells to grow and metastasize. They say the discovery ...

ROCHESTER, Minn. – Researchers at Mayo Clinic have found patients who use gastric suppression medications are at a higher risk for recurrent Clostridium difficile (C-diff) ...

After nearly a month orbiting the Earth attached to the International Space Station, the SpaceX Dragon capsule containing Dr. Abba Zubair's stem cell research ...

Transforming medical practice through sex and gender-based research has been the focus of physiologist and surgical researcher Virginia Miller's work for over 25 years. She says ...

At Mayo Clinic, Marina Ramirez-Alvarado, Ph.D., studies one type of protein abnormality associated with a complex and incurable disease called light chain amyloidosis. This type ...

“I hope you go home at night and realize that you are changing the world.” – Dr. Alex Parker to team members on transforming medicine. ...

ROCHESTER, Minn. ― U.S. News & World Report today released its 2018 rankings for Best Graduate Schools across the nation. Mayo Clinic School of Medicine ...

ROCHESTER, Minn. — Everyone knows that exercise is good for you, but what type of training helps most, especially when you’re older - say over ...